· Philippines
Philippines: FDA warns on unauthorized Kevin & Coco lip gloss
On 12 August 2026 the Philippine FDA issued Advisory No. 2026-0879 warning against purchase and use of the unauthorized cosmetic Kevin & Coco Juicy Lip Gloss.
Latest regulatory updates
Concise guidance notes and market signals across ASEAN and Asian health authorities — linked from country pages for faster SEO freshness.
· Taiwan
Taiwan: TFDA shifts device submissions to online review from October
On 25 August 2026 TFDA announced that from 1 October 2026 device registration, variation and extension filings will use online review with originals kept on file, and paper label approvals will stop.
· Thailand
Thailand: Thai FDA asks nitrite salt to be coloured pink
On 8 August 2026 the Thai FDA announced a voluntary measure for nitrite-mixed salt sold to food preparers: add a pink colour and a red warning on the label, ahead of a draft legal requirement.
· Singapore
Singapore: HSA consults on complementary health product regulation
On 1 July 2026 HSA opened a stakeholder consultation on moving complementary health products under the Health Products Act, with comments due by 29 July 2026.
· Malaysia
Malaysia: NPRA directs use of the July 2026 DRGD revision
NPRA posted on 16 July 2026 a directive dated 10 July 2026 requiring use of the Drug Registration Guidance Document, Third Edition, 12th Revision July 2026.
· Indonesia
Indonesia: BPOM finds 14 unsafe cosmetics in Q2 2026
On 13 July 2026 BPOM reported 14 cosmetics from second-quarter surveillance that contained hazardous or prohibited substances, including products with no marketing authorization.
· Philippines
Philippines: FDA issues AO 2026-0011 on Codex food additives
On 23 July 2026 the Philippine FDA listed Administrative Order 2026-0011, revising adoption of the Codex General Standard for Food Additives and processing aids and repealing AO 88-A s. 1984.
· Taiwan
Taiwan: TFDA requires risk plans for semaglutide and tirzepatide
On 23 July 2026 TFDA announced a risk-evaluation and control plan for products containing semaglutide or tirzepatide, with a three-month deadline for current license holders.
· Thailand
Thailand: Thai FDA undergoes PIC/S reassessment
On 14 July 2026 the Thai FDA reported that it is undergoing a PIC/S reassessment to maintain membership, covering the inspectorate, laboratory and observed GMP inspections.